Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1377-1386

  Winter, Rachel N ^a   Rhee, Juong G ^a   Kyprianou, Natasha ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Caspase 1; Prostate cancer; Radiation

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BENZYLOXYCARBONYLTYROSYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PENTAPEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL CLONING; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION PROFILING; GENE TRANSFER; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION; RADIATION DOSE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 1; CELL LINE, TUMOR; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 3242674432     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer Statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Isaacs W.B, Bova GS, Morton RA, Bussemakers MJ, Brooks JD and Ewing CM: Molecular biology of prostate cancer. Semin Oncol 21: 514-521, 1994.
3. Szostak MJ and Kyprianou N: Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer. Oncol Rep 7: 699-706, 2000.
4. Sklar GN, Eddy HA, Jacobs SC and Kyprianou N: Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J Urol 150: 1526-1533, 1993.
5. Schellhammer PF: Radiation therapy for localized prostate cancer: what has been and still remains to be learned. In: Monographs in Urology. Stamey T (ed.) Stanford CA, Medical Directions Publishing 15: 78-92, 1994.
6. Kyprianou N, King ED, Bradbury D and Rhee JG: Bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 70: 341-348, 1997.
7. Eiseman JL, Rogers FA, Guo Y, Kauffman J, Sentz DL, Klinger MF, Callery PS and Kyprianou N: Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. Cancer Res 58: 4864-4870, 1998.
8. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW and Mak TW: Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819, 1998.
9. Bruckheimer EM and Kyprianou N: Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 301: 153-162, 2000.
10. Huang A, Gandour-Edwards R, Rosenthal SA, Siders DB, Deitch AD and White RW: p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy. Urology 51: 346-351, 1998.
11. Scherr DS, Vaughan ED, Jr, Wei J, Chung M, Felsen D, Allbright R and Knudsen BS: Bcl-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol 162: 12-16, 1999.
12. Szostak MJ, Kaur P, Amin P, Jacobs SC and Kyprianou N: Apoptosis and bcl-2 exprsesion in prostate cancer: significance in clinical outcome after brachytherapy. J Urol 165: 2126-2130, 2001.
13. Juin P and Evan G: Caspase 8: the killer you can't live without. Nat Med 6: 498-500, 2000.
14. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
15. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87: 171-177, 1996.
16. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
17. Rokhlin OW, Glover RA and Cohen MB: Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. Cancer Res 58: 5870-5875, 1998.
18. Slee EA, Adrain C and Martin SJ: Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6: 1067-1074, 1999.
19. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J et al: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774, 1992.
20. Alnemri ES, Fernandes-Alnemri T and Litwack G: Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J Biol Chem 270: 4312-4317, 1995.
21. Miura M, Zhu H, Rotello R, Hartwieg EA and Yuan J: Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-60, 1993.
22. Whyte M: ICE/CED-3 proteases in apoptosis. Trends in Cell Biol 6: 245-248, 1996.
23. Ueki T, Takeuchi T, Nishimatsu H, Kajiwara T, Moriyama N, Narit Y, Kawabe K, Ueki K and Kitamura T: Silencing of the caspase-1 gene occurs in murine and human renal cancer cells and causes solid tumor growth in vivo. Int J Cancer 91: 673-679, 2001.
24. Guo Y and Kyprianou N: Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res 59: 1366-1371, 1999.
25. Tatsuta T, Shiraishi A and Mountz JD: The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation. J Biol Chem 275: 14248-14254, 2000.
26. Winter RN, Kramer A, Borkowski A and Kyprianou N: Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61: 1227-1232, 2001.
27. Guo Y and Kyprianou N: Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ 9: 185-193, 1998.
28. Thornberry NA: Caspases: key mediators of apoptosis. Chem Biol 5: R97-103, 1998.
29. Kimura K and Gelmann EP: Tumor necrosis factor-alpha and Fas activate complementary Fas- associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation. J Biol Chem 275: 8610-8617, 2000.
30. Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM and Slawin KM: Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Cancer Res 61: 2562-2571, 2001.
31. Takahashi H, Nakamura S, Asano K, Kinouchi M, Ishida-Yamamoto A and Iizuka H: Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspases 8, 3, and 1 in the apoptotic process. Exp Cell Res 249: 291-298, 1999.
32. Schlosser S, Gansauge F, Ramadani M, Beger HG and Gansauge S: Inhibition of caspase-1 induces cell death in pancreatic carcinoma cells and potentially modulates expression levels of bcl-2 family proteins. FEBS Lett 491: 104-108, 2001.
33. Lin XY, Choi MS and Porter AG: Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 275: 39920-39926, 2000.
34. Gupta S, Radha V, Furukawa Y and Swarup G: Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem 276: 10585-10588, 2001.
35. Gartel AL, Serfas MS and Tyner AL: p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 213: 138-149, 1996.
36. Sarkar FH, Li Y, Sakr WA, Grignon DJ, Madan SS, Wood DP Jr and Adsay V: Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa). The Prostate 40: 256-260, 1999.
37. Tian H, Wittmack EK and Jorgensen TJ: p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 60: 679-684, 2000.
38. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
39. Bookstein R, Shew JY, Chen PL, Scully P and Lee WH: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712-715, 1990.
40. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992.